https://www.investors.com/news/technology/crispr-gene-editing-biotech-companies/ … Read more
Visual-Science
https://visual-science.com/projects/ … Read more
CES 2018 Gadget
FierceBiotech’s hotlist of 15 for 2017
FierceBiotech’s hotlist of 15 for 2017
- Axial Biotherapeutics
- Aravive Biologics
- BlackThorn Therapeutics
- Gritstone Oncology
- Magenta Therapeutics
- PMV Pharma
- PsiOxus Therapeutics
- Relay Therapeutics
- Repare Therapeutics
- Rubius Therapeutics
- Tango Therapeutics
- Turnstone Biologics
- Vir Biotechnology
- Vivet Therapeutics
- Vividion Therapeutic
Gene Therapy for Osteoarthritis cure.
South Korea OKs First-in-Class Gene Therapy for Osteoarthritis
South Korea’s Ministry of Food and Drug Safety said today that it has approved the country’s first gene therapy for osteoarthritis, the lead product candidate of a Maryland-based regenerative medicine company.
Invossa-K Inj. was developed by Maryland-based TissueGene, whose Korean licensee, Kolon Life Sciences, won approval for the injectable treatment. According to the company, Invossa is a first-in-class cell-mediated gene therapy designed to treat moderate (Kellgren and Lawrence grade 3) knee osteoarthritis through regeneration of cartilage.
Invossa uses allogeneic human cartilage cells
Whats is Optogenetics
Optogenetics
From Wikipedia, the free encyclopedia
Optogenetics (from Greek optikós], meaning “seen, visible”) is a biological technique which involves the use of light to control cells in living tissue, typically neurons, that have been genetically modified to express light-sensitive ion channels. It is a neuromodulation method employed in neuroscience that uses a combination of techniques from optics and genetics to control and monitor the activities of individual neurons in living tissue—even within freely-moving animals—and to precisely measure the effects of those manipulations in real-time.[1] The key reagents used in optogenetics … Read more
PDUFA Dates remaining in 2016
Hemophilia B cure by gene therapy
|
Knee Replacement
Gene therapy for osteoarthritis ?
GeneQuine develops drugs that are based on gene therapy. The concept of gene therapy is to introduce genetic material into the patient’s own cells in the body. The cells produce then a therapeutic protein according to the template that the introduced genetic material (DNA) provides
GeneQuine is focused on the development of gene therapy agents for the treatment of osteoarthritis. Osteoarthritis is a degenerative joint disorder characterized by cartilage loss and inflammation. Patients affected by osteoarthritis experience joint pain as well as swelling and stiffness of the joints leading to … Read more